DO GLUTAMIC-ACID DECARBOXYLASE ANTIBODIES IMPROVE THE PREDICTION OF IDDM-I IN FIRST-DEGREE RELATIVES AT RISK FOR IDDM
Details
Publication Year 1994-12,Volume 7,Issue #6,Page 873-879
Journal Title
JOURNAL OF AUTOIMMUNITY
Publication Type
Journal Article
Abstract
To determine whether the predictive value of islet cell antibodies (ICA) and insulin autoantibodies (IAA) is increased by measurement of glutamic acid decarboxylase antibodies (GADAb) in first-degree relatives of patients with insulin-dependent diabetes mellitus (IDDM), we measured GADAb in those developing IDDM and in relatives found to be ICA- or IAA-positive in our family screening study. First-degree relatives (n=2904) were followed for 2.4 (median, range 0.04-5.8) years. Of the subjects developing IDDM, 11/14 (78%) had ICA greater than or equal to 20JDF units, 1/14 (7%) had IAA greater than or equal to 100 nU/ml and 6/14 (43%) had GADAb (greater than or equal to 460nU/ml, measured by precipitation of enzymatic activity). Of the four subjects with ICA<Z0 and IAA<100 nU/ml who developed IDDM, one had elevated GADAb. Significant inhibition of GAD enzymatic activity by serum immunoglobulins, a potential cause of false-negative results in our immunoprecipitation assay, was not detected in seven subjects who developed IDDM in the absence of GADAb. Sixty-nine of the 2904 subjects with ICA greater than or equal to 20 or IAA greater than or equal to 100 were followed for 3.1 (median range 0.1-5.4) years. Survival analysis showed that diabetes-free survival in this group was not influenced significantly by GADAb positivity. In conclusion, GADAb in the absence of ICA and IAA are uncommon in first-degree relatives who progress to IDDM and the presence of GADAb does not increase the risk for IDDM in ICA- or IAA-positive relatives.
Publisher
ACADEMIC PRESS LTD
Keywords
ISLET-CELL ANTIBODIES; DEPENDENT DIABETES-MELLITUS; INSULIN AUTOANTIBODIES; INDIVIDUALS; POPULATION
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 1994-12-01 12:00:00
An error has occurred. This application may no longer respond until reloaded. Reload 🗙